logo

VYNE Therapeutics Inc (VYNE) Stock: A Year of Highs and Lows in the Market

CROX

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. VYNE Therapeutics Inc’s current trading price is -64.83% away from its 52-week high, while its distance from the 52-week low is 83.83%. The stock’s price range over this period has fluctuated between $1.67 and $8.73. The company, operating within the financial sector, had a trading volume of approximately 0.29 million for the day, which was noticeably higher than the average daily share volume of 0.12 million over the last 3 months.

VYNE Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $8.73 on 05/09/23, while the lowest price for the same period was registered at $1.67 on 01/31/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

VYNE Therapeutics Inc (VYNE) has experienced a quarterly rise of 19.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 43.29M and boasts a workforce of 10 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.57, with a change in price of +0.03. Similarly, VYNE Therapeutics Inc recorded 107,479 in trading volume during the last 100 days, posting a change of +0.99%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VYNE stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

VYNE Stock Stochastic Average

Today, VYNE Therapeutics Inc’s raw stochastic average for the past 50 days stands at 93.98%, indicating a rise from the raw stochastic average of the last 20 days, which was 92.89%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 83.62% and 74.80% respectively.

VYNE Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 31.76% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -25.67%. Over the past 30 days, the price of VYNE has fallen by 31.76%. And in the last five days, it has surged by 31.76%.